Custom organic synthesis:

SynChem fully commit itself to be the most reliable organic chemistry powerhouse and to be the best organic chemistry outsourcing provider for drug discovery and biotech companies.  Our expertises are:

·        Starting materials, intermediates, and final products

·        Combinatorial chemistry templates and building blocks

·        Reference compounds (literature or competitor), impurities, by-products

·        Drug intermediates synthesis

·        Scale up, process optimization

 SynChem has a proven track record in supplying pharmaceutical and biotechnology companies with gram to kilogram quantities of high quality custom-made organic chemicals and on-time delivery.  Our marketing team will quickly response to your inquiries (Two working days) and aggressive timing on bid (Average quote for job completion is 5 weeks).  Our production team is highly reliable, especially on delivery time (Average completion date is 5 days before project due date).

Our customers include: Eli Lilly & Co., Bristol-Myers Squibb, Amgen, Inc., Helios Pharmaceuticals, Kosan Biosciences, Neurocrine Biosciences, ArQule, Inc., Neurogen Corporation, Schering-Plough, and many other pharmaceutical companies.

Contract research:

SynChem, Inc. is a research and development company specializing in custom syntheses and contract research.  In addition to synthesizing specific organic compounds, SynChem offers its research facilities for the development of new products, particularly in the areas of focused combichem libraries, combinatorial chemistry building blocks, heterocycles and other organic intermediates.

·        Process research and development

·        Generating focused library

·        Lead optimization by combinatorial chemistry approach

·        Organic synthesis and medicinal chemistry projects. 

Currently, we are concentrating on developing new synthetic methods for combinatorial chemistry templates and building blocks, heterocylic compounds, chiral building blocks, and other important organic building blocks.  Our Company has been awarded three Small Business Innovation Research (SBIR) grant from the US National Institutes of Health (NIH).  Last two years our research team has published more than six research papers and filed two patent applications, and developed three series combinatorial chemistry building blocks (see our news section).